Dibutyl phthalate (DBP) is used worldwide in solvents and plasticizers. The cytotoxicity and potential tumorigenic effect of DBP have been reported. DBP has also been shown to impact reproductive function. In this study, to further evaluate the effects of DBP on granulosa cells (GCs), we treated rat GCs in vitro with DBP before evaluation of the biological alterations of these GCs. We found that DBP did not induce significant GC death at the tested concentrations. However, follicle-stimulating hormone (FSH)-induced KIT ligand (KITLG) expression in GCs was significantly reduced at both mRNA and protein levels by DBP treatment in a dose-dependent manner. The downregulation of KITLG was due to the down-regulation of expression of FSH receptor (FSHR) in GCs. Down-regulation of FSHR impaired FSH-induced intracellular signaling in GCs, demonstrated by decreased phosphorylation of AKT and mechanistic target of rapamycin (mTOR). Furthermore, DBP treatment also reduced FSH-induced expression of hypoxiainducible factor 1-alpha (HIF1A), which is an important signaling component for KITLG expression. Other FSH-induced biological effects, such as production of estradiol and progesterone, as well as GC proliferation, were also suppressed by DBP. Therefore, our study discovered a unique mechanism underlying the toxicity of DBP on GCs. These findings may initiate the development of novel therapeutic interventions for DBP-induced damage to GCs. dibutyl phthalate, follicle-stimulating hormone (FSH/FSH receptor), granulosa cells, hypoxia-inducible factor 1-alpha, Kit ligand
INTRODUCTION
Dibutyl phthalate (DBP) is one of the phthalic acid esters used in making flexible plastics that are found in a variety of consumer products. DBP can be released into the environment through its production and incorporation into products because DBP is not bound to the final product. The potential risk of DBP to human health has been investigated. In humans and in rats, DBP is metabolized to mono-n-butyl phthalate [1] . Animal studies have documented the potential toxic effects of DBP on multiple organs and tissues depending on the mechanism of exposure [2] [3] [4] . Although these studies show that DBP is not acutely systemically toxic, notable alterations at cellular and molecular levels have been observed. One study showed that DBP induces decreases in both microsomal cytochrome P450 (aromatase) and cytochrome c reductase. This could result in alterations in metabolism pathways [5] . Furthermore, DBP also induces significant biological changes in various cell types, including embryonic limb bud cells [6] , epithelial cells [7] , and several tumor cell lines [8] [9] [10] . Of note, a recent study revealed the role of DBP in impairing reproductive function. Impairment of in vitro spermatogenesis caused by DBP could be partially due to the suppression of androgen-binding protein and inhibin alpha biosynthesis [11] . DBP also affects the testicular functions in vivo [12] [13] [14] . However, these studies mainly focused on the male reproductive system. The effects of DBP on the female reproductive system are still poorly understood.
Granulosa cells (GCs) surround the oocyte and are bound to the zona pellucida within the ovary follicle [15] . They produce estrogen before ovulation and progesterone after ovulation to keep the uterus ready to implant an egg, and sustain a pregnancy if fertilization occurs. The interaction between GCs and the oocyte has gained much attention because of its importance in regulating ovarian follicle development. Throughout growth, the oocyte remains coupled to its GCs by gap junctions, intercellular channels that permit small molecules to pass freely between opposing cells. In addition, GCs and oocytes produce differential cytokines and growth factors, such as KIT ligand (KITLG), growth differentiation factor-9 (GDF9), and bone morphogenetic protein-15 (BMP15) that regulate the development and function of each other [15] [16] [17] . Moreover, GCs participate in modulating the lineage specification of ovarian theca cells [18] , further demonstrating their crucial role in the development of ovarian follicles. The potential effects of DBP on GCs have not been fully understood. Recent research has shown that DBP-treated follicles have decreased mRNA for cyclins D2, E1, A2, and B1 and antiapoptotic gene Bcl2, as well as increasing levels of Bid and p21 Cip1 [19] . These changes might reflect the alterations of GC activity because of the large amount of GCs in ovarian follicles.
In this study, we evaluated the effects of DBP on GCs in an in vitro culture system. We treated rat GCs with DBP and then investigated the biological alterations of these GCs, especially the changes in the expression of molecules that are important for oocyte growth and survival. We found that folliclestimulating hormone (FSH)-induced KITLG expression in GCs was significantly reduced at both mRNA and protein levels by DBP treatment in a dose-dependent manner. The down-regulation of KITLG was associated with reduction of expression of FSH receptor (FSHR). Down-regulation of FSHR impaired FSH-induced cell signaling in GCs. Furthermore, DBP-induced impairment of FSH signaling downregulated expression of hypoxia-inducible factor 1-alpha (HIF1A), which is an important signaling component for KITLG expression. Exogenous HIF1A expression after lentiviral transduction restored the KITLG expression in GCs. Other FSH-induced biological effects were also suppressed by DBP. Therefore, our study discovered a unique mechanism underlying the toxicity of DBP to GCs. Our findings may provide clues for understanding DBP-induced damage to GCs.
MATERIALS AND METHODS

GC Culture Without Oocytes and DBP Treatment
All animal experiments were conducted in compliance with institutional guidelines and Fujian Medical University Guidelines for the Use of Animals. All animal procedures were approved by the Fujian Medical University Animal Care and Use Committee. GCs were isolated and cultured based on established protocol [20] . Female 25-day-old Sprague Dawley rats were killed and the ovarian follicles were punctured with a 28-gauge needle, and the isolated mixture of GCs and oocytes was resuspended in serum-free McCoy 5a medium (Life Technologies) supplemented with 2 mM L-glutamine and antibiotics. GCs were separated from oocytes by filtering 5 ml of the oocyte/GC suspension through a nylon mesh (40 lm; BD Falcon), which allowed GCs but not oocytes to pass through. The purified GCs were adjusted to 3.5 3 10 5 /ml and were cultured in serum-free supplemented McCoy 5a medium in 24-well or 6-well microplates at 378C before DBP treatment. DBP (Sigma-Aldrich) was dissolved in dimethyl sulfoxide (DMSO; Sigma-Aldrich) at 20 mg/ml as a stock and stored at À208C. Before treatment, DBP was diluted in DMSO to 0.5, 2, and 10 mg/ml. Then DBP was added into GC culture at 1:100 (v:v) to reach the final concentrations of 5, 20, and 100 lg/ml. These doses of DBP were supposedly not significantly cytotoxic to GCs based on a previous study showing the cytotoxicity of DBP on mouse ovarian antral follicles [19] . Control cells were incubated in the culture medium containing an equivalent volume of DMSO without DBP. GCs were treated for 24 or 48 h before further analysis. In some experiments, 100 ng/ml human FSH (Sigma-Aldrich) and/or 100 ng/ml activin A (Peprotech) was added to the cultures after DBP treatment for an additional 24 h.
Follicle Culture
Ovaries were collected from 25-day-old rats, and preantral follicles (about 150 lm in diameter) were dissected microscopically using fine needles. Follicles were isolated and pooled from three to four rats and were cultured in Eagle MEM (Life Technologies) supplemented with penicillin, streptomycin, Lglutamine, and 0.1% bovine serum albumin (Sigma-Aldrich) in the absence of hormones or agents. The cultures were incubated at 378C under 95% O 2 and 5% CO 2 . After 24 h, follicles were collected, and 10-15 follicles were plated per treatment for each follicle culture experiment. Then, 100 lg/ml DBP was added into each follicle culture and incubated for 24 h. Subsequently, follicles were subject to further analysis. In some experiments, 100 ng/ml FSH was added into follicle culture after DBP treatment.
Flow Cytometry
For detection of cell death, GCs were incubated in 2 mM EDTA-PBS at 378C for 10 min. Cells were gently flushed with a pipette to dissociate cells from the bottom of wells. Cells were then centrifuged and stained with propidium iodide (BD Biosciences) and annexin V (BD Biosciences) according to the manufacturer's instructions. Briefly, cells were washed with PBS twice and were incubated in 100 ll of binding buffer (10 mM HEPES, pH 7.4; 140 mM NaCl; 2.5 mM CaCl 2 ) containing annexin V-biotin (1:20) for 15 min at room temperature in the dark. Cells were then washed with PBS once followed by incubation in 100 ll of binding buffer containing 5 lg/ml propidium iodide and 5 lg/ml streptavidin-fluorescein isothiocyanate (FITC; BD Biosciences) for 15 min at room temperature in the dark. Four hundred microliters of binding buffer was added to each sample. Apoptosis was analyzed by flow cytometry within 1 h. Apoptotic cells were identified as annexin V-positive cells. Necrotic cells were identified as propidium iodide (PI)-positive cells.
For detection of FSHR expression, Alexa Fluor 488-conjugated rabbit anti-FSHR polyclonal antibody (Bioss Antibodies) was used to stain GCs on ice for 30 min followed by analysis on a BD LSRII flow cytometer. Alexa Fluor 488-conjugated rabbit anti-rat IgG (Life Technologies) was used as isotype control.
For KITLG detection, cells were fixed and permeabilized with BD Cytofix/ perm and Perm/wash buffer according to the manufacturer's manual. Cells were then stained at room temperature for 30 min with rabbit anti-SCF polyclonal antibody (Bioss Antibodies), followed by staining with Alexa Fluor 488-conjugated goat anti-rabbit IgG (Life Technologies) for 30 min at room temperature. Cells were then analyzed on the BD LSRII flow cytometer.
FSH-Binding Assay
We incubated 3.5 3 10 5 /ml GCs with or without 100 lg/ml DBP at 378C for 24 h. Cells were then washed with PBS twice, resuspended in FACS Buffer (PBS, 0.5%-1% bovine serum albumin or 5%-10% fetal bovine serum, 0.1% NaN3 sodium azide) and put on ice for 5 min. Then, 1 lg/ml human FSH was added into cell suspension and incubated on ice for 30 min. After two washes with PBS, cells were incubated with FITC-conjugated rabbit anti-human FSH beta antibody (diluted 1:10 in FACS buffer; LifeSpan BioSciences) for 15 min on ice. Cells were then loaded on the BD LSRII flow cytometer for analysis.
RNA Isolation, Reverse Transcription, and Quantitative PCR Total RNA was isolated from cells using the RNeasy Mini Kit (Qiagen). One microgram of total RNA from each sample was transcribed into cDNA using SuperScript III First-Strand Synthesis System (Invitrogen) according to the manufacturer's instructions. The quantitative PCR (q-PCR) was performed using Fast SYBR Green Master Mix (Invitrogen) on a 7300 q-PCR System (Invitrogen). Data was analyzed with 7300 System software. Primer sequences for each gene are as follows (5 0 to 3 0 forward and reverse): beta-actin (Actb), (AGAGGGAAATCGTGCGTGAC and CAATAGTGATGACCTGGCCGT); KITLG (Kitlg) (TGTTGCAGCCAGTTCCCTTA and GGCTCCAAAAGC AAAGCCAA); bone morphogenetic protein-2 (Bmp2) (ATATGCTCGACC TGTACCGC and CGGGACGTTTTCCCACTCAT); bone morphogenetic protein-5 (Bmp5) (CTCTCATCAGGACCCCTCCA and CGGCATATC CTTCTGGTGCT); bone morphogenetic protein-6 (Bmp6) (CAGAGTCGC AATCGGTCCAC and GTAGCCTTTGGGTGCGATGA); activin A (Inhba) (GACCTCATGAGACAAGAGCCG and AGTCGTGTGGTTGCCTTCTT); antimü llerian hormone (Amh) (GGAGAGACTGGGGAACAGCA and CCAGGTCCAGGGTATAGCAC); aromatase (cytochrome P450 family 19 subfamily A member 1, Cyp19a1) (TAACAACAACCCGAGCCTGT and CGTAGCCCGAGTTGTCAGTG); and FSHR (Fshr) (CATCACT GGCTGTGTCATTGCT and GCAAATGATCCTTTCGGGATGAC). PCR conditions used for all primer sets were as follows: 958C hot start for 10 min, followed by 40 amplification cycles of 958C for 30 sec (denaturing), 608C for 1 min (annealing, extension and detection). Relative abundance of RNA was analyzed using the 2 ÀDDCt method.
WANG ET AL.
Western Blot
The whole cellular proteins were extracted with RIPA buffer (10 mM TrisCl [pH 8.0], 1 mM EDTA, 0.5 mM EGTA, 1% Triton X-100, 0.1% sodium deoxycholate, 0.1% SDS, 140 mM NaCl). The following antibodies were used: anti-beta-actin (sc-47778), anti-KITLG (sc-9132), anti-phospho AKT (Thr 308, sc-135650), anti-AKT (sc-8312), anti-phospho-mechanistic target of rapamycin (mTOR) (Ser 2448), anti-mTOR (sc-136269), anti-phospho-CREB (Ser 133, sc-7978), anti-CREB (sc-186), anti-HIF1A (sc-10790), and anti-steroidogenic factor 1 (SF1; sc-393592), were purchased from Santa Cruz Biotechnology. Anti-FSHR (ab75200) and anti-aromatase (ab71264) were purchased from Abcam. Anticholesterol side-chain cleavage enzyme (P450SCC, ABS235) was purchased from EMD Millipore. Membranes were developed with SuperSignal West Pico Chemiluminescent Substrate (Thermo Scientific) and the optical density was analyzed using a Biospectrum 500 imaging system. The specificity of anti-KITLG and anti-FSHR antibodies was confirmed in the pilot experiments (Supplemental Fig. S1 ; Supplemental Data available online at www.biolreprod.org). 
DIBUTYL PHTHALATE IMPAIRS GRANULOSA CELL FUNCTION
3
Article 144
Overexpression of HIF1A with Lentivirus Transduction
The lentivirus vector containing rat Hif1a cDNA (pLenti-GIII-CMV-Rat-HIF1A-GFP-2A-Puro) and third-generation packaging system were purchased from Abm Inc. Packaging of lentiviral particles was performed on HEK293 cells following the manufacturer's manual. Transduction of GCs with lentiviral particles was conducted according to previous publications [21, 22] with modifications. Briefly, 2.5 3 10 5 GCs were plated into a 12-well plate 24 h before transduction. On the day of transduction, the medium was replaced by fresh medium containing 5 lg/ml polybrene. Lentiviral particles were added into cell culture at the multiplicity of infection of 10 and were incubated with cells overnight. The virus-containing medium was then replaced by polybrenefree fresh medium and cells were incubated for 48 h to allow for expression of the gene of interest. Transduction efficiency was evaluated by the percentage of GFP-expressing cells using flow cytometry analysis. HIF1A expression was analyzed by Western blot.
Luciferase Reporter Assay
A luciferase reporter vector containing the rat Fshr promoter region (À100 and þ123 bp relative to the first transcriptional start site) was constructed according to the previous literature [23] . First, 1 3 10 5 GCs were plated in 24-well plates. The next day, 1 lg luciferase reporter vector was transfected using Lipofectamine 2000 (Life Technologies). Six hours later, the DNA was removed and the cells were washed and cultured in the presence or absence of DBP for 24 h. At that time, the cells were lysed by freeze-thaw procedure using lysis buffer (0.2 m Tris, pH 8.0, containing 0.1% Triton X-100). Cytosolic protein concentrations were determined by the mini-Bradford assay (Bio-Rad Laboratories, Inc.). Luciferase activity in the extracts was analyzed according to a standard protocol. In brief, a 20-ll aliquot of the cell lysate was mixed automatically with 100 ll of the luciferase assay reagent (20 mM Tris, pH 8.0, containing 4 mM MgSO4, 0.1 mM EDTA, 30 mM dithiothreitol, 0.5 mM ATP, 0.5 mM luciferin, and 0.25 mM Coenzyme A [CoE A]) and the reaction was monitored in a GloMax 96 microplate luminometer (Promega). Relative luciferase activity was calculated by normalizing data of treated samples to the data of the untreated control group.
Thymidine Incorporation
We seeded 5 3 10 4 GCs in 96-well plates in the presence of different hormones and peptides. We added ( 3 H) thymidine (4 lCi/ml) to the cultures in the presence or absence of stimuli and/or 100 lM DBP. After 24 h of culture, the radioactivity was determined in scintillation fluid by counting in a betaphotomultiplier as previously described [24] .
ELISA
The supernatant from each GC culture was collected at the end of treatment and stored at À808C. Supernatant samples were randomly selected from all experiments and subjected to ELISA. Levels of 17-beta-estradiol and progesterone in supernatants were measured using kits from Abcam (ab108667) and BioVendor Laboratory Medicine (RTC008R) according to the manufacturer's instructions.
Statistics
Quantitative data were expressed as mean 6 SEM from the indicated number of experiments. For experiments with more than two groups, data were analyzed by one-way ANOVA followed by Fisher protected least significant difference (PLSD) post hoc tests. For experiments with only two groups, Student t-test was used for comparison of means between the groups. P values ,0.05 were considered significant.
RESULTS
DBP Is Not Cytotoxic to GCs
DBP was shown to be cytotoxic to rat embryonic limb bud cells [6] and mouse peritoneal macrophages [25] . To evaluate the potential cytotoxicity of DBP to GCs, we treated GCs with DBP at 5, 20, and 100 lg/ml for 48 h in vitro. Flow cytometry analysis indicated that DBP did not significantly induce apoptosis of GCs, as demonstrated by comparable proportions of apoptotic (annexin V-positive) and necrotic (PI-positive) cells among all groups (Fig. 1, A and B) . Hence, DBP was not cytotoxic to GCs at the indicated concentrations. We also tested apoptosis of GCs in the presence of DBP and 100 ng/ml FSH. It turned out that DBP did not induce GC apoptosis when FSH was present (Fig. 1, C and D) .
DBP Decreases FSH-Induced KITLG Expression in GCs
KITLG is an important GC-derived cytokine that promotes oocyte growth and maturation [26, 27] . To investigate whether DBP affects KITLG production in GCs, we determined Kitlg mRNA level by q-RT-PCR. As shown in Figure 2 , A and B, DBP did not change the basal level of Kitlg mRNA. The mRNA levels of other granulosa cell-derived cytokines, such as Bmp2, Bmp5, Bmp6, Inhba, and Amh, were not significantly altered after DBP treatment. However, when FSH profoundly increased Kitlg mRNA in GCs, DBP decreased FSH-induced up-regulation of Kitlg mRNA at 20 and 100 lg/ml (Fig. 2C) . Western blot assay confirmed comparable basal levels of KITLG proteins among groups treated without or with DBP alone (Fig. 2D) . FSH up-regulated both KITLG1 and KITLG2 proteins, and DBP diminished the effect of FSH at 20 and 100 lg/ml (Fig. 2, E and F) . We also performed flow cytometry to analyze the proportion of KITLG-expressing GCs after treatment. FSH remarkably increased the percentage of KITLG-expressing cells, and 20 and 100 lg/ml DBP reduced the percentage of KITLG-expressing cells (Fig. 2G) . Taken together, our data suggest that DBP inhibits FSH-induced KITLG expression in GCs.
DBP Inhibits FSHR Expression in GCs
The inhibitory effect of DBP on FSH-induced KITLG expression suggests that the signal transduction downstream of FSH-FSHR engagement might be impaired. This effect could be the result of the reduction of FSHR expression or the blockade of certain signal cascades. Thus, we determined FSHR expression in GCs after DBP treatment. We found that DBP down-regulated FSHR expression at the mRNA level (Fig. 3A) and the protein level (Fig. 3, B and D) in a dosedependent manner. To explore whether transcription of the Fshr gene was suppressed by DBP, we conducted the luciferase reporter assay, in which luciferase expression is controlled by the Fshr promoter region. We found that 20 and 100 lg/ml DBP significantly reduced the signal in comparison with the untreated control group, suggesting that transcription of the Fshr gene was indeed inhibited by DBP (Fig. 3C) . Consistent with decreased FSHR expression, FSH-induced phosphorylation of AKT and cAMP response element-binding protein (CREB) was also decreased in DBP-treated cells (Fig.  3E) . Notably, DBP itself did not significantly change the phosphorylation of CREB, AKT, and mTOR (Fig. 3F) , suggesting that the down-regulation of FSH-induced cell signaling observed in Figure 3E was not due to the direct inhibitory effect of DBP on these signal pathways. To directly test the binding of FSH to FSHR, GCs were treated with vehicle (DMSO) or 100 lg/ml DBP for 24 h. Then FSH was added into cells. Ligation of FSH to FSHR was tested using FITC-conjugated anti-FSH antibody. As shown in Figure 3G , DBP-treated GCs had much lower FITC signal, suggesting less FSH bound to FSHR on DBP-treated GCs in comparison with vehicle-treated GCs.
DBP Inhibits KITLG Expression Through Down-Regulation of HIF1A Expression
Previously, the mechanism by which FSH regulates KITLG expression in GCs was not completely understood. Past studies showed that FSH enhances HIF1A expression through phosphatidylinositol-3 kinase (PI-3K)/AKT and mTOR pathways [28, 29] . HIF1A regulates the expression of many proteins including KITLG [30] [31] [32] . Hence, we hypothesized that FSH enhances KITLG expression through HIF1A, and DBP inhibits FSH-induced HIF1A expression and subsequently down-regulates KITLG production. Our study found that FSH does induce higher phosphorylation of mTOR and p70S6K in GCs, and that DBP remarkably inhibits phosphorylation of AKT, mTOR, and p70S6K (Fig. 4, A and B) . The inhibitory effect of DBP was relatively weaker than that of wortmannin, which is a specific PI3K inhibitor (Fig. 4, A and  B) . HIF1A protein was also reduced by DBP and wortmannin in association with the lower PI3K/AKT-mTOR signaling (Fig.  4, A and B) . DBP did not significantly change the basal phosphorylation of p70S6K and basal expression of HIF1A (Supplemental Fig. S2 ). To determine the role of PI3K in the regulation of HIF1A, we used a PI3K activator, 740 Y-P, to treat the cells in the presence of FSH and DBP. As shown in Figure 4C , 740 Y-P increased phosphorylation of AKT and mTOR in the presence of DBP, suggesting activation of PI3K signaling. Moreover, HIF1A expression was also up-regulated by 740 Y-P in the presence of DBP (Fig. 4C) , suggesting PI3K pathway indeed induces HIF1A expression. To further confirm the role of HIF1A, we constructed a lentivirus in which expression of HIF1A was controlled by the CMV promoter. Transduction of this lentivirus into GCs was highly efficient, as demonstrated by over 90% GFP-positive cells 2 days after transduction (Fig. 4D) . The lentivirus-derived HIF1A expression was confirmed by Western blot (Fig. 4E) . Importantly, exogenous HIF1A partially restored KITLG expression in GCs treated with DBP and FSH (Fig. 4E) , suggesting that HIF1A induces KITLG expression and DBP inhibits FSH-induced KITLG expression through down-regulation of FSH-induced HIF1A.
DBP Suppresses Other Biological Activity of FSH on GCs
DBP-induced down-regulation of FSHR expression poses the possibility that other FSH-related biological activities might also be influenced by DBP. To test this hypothesis, we determined expression of estradiol, progesterone, and aromatase in FSH-treated GCs in the presence or absence of DBP. A previous study showed that DBP decreases estradiol production but does not influence progesterone production by mouse ovarian antral follicles [19] . We found that DBP inhibited FSHinduced expression of these molecules (Fig. 5, A-C) . However, exogenous HIF1A could not restore their expression, suggesting that HIF1A might not be involved in sex hormone production in GCs. The synergistic effect of FSH on activin Ainduced proliferation of GCs was also attenuated by DBP, as demonstrated by lower thymidine uptake in the presence of DBP (Fig. 5D) . DBP did not alter GC proliferation induced by activin A alone (Fig. 5D) . Western blot assay indicated that the expression of FSH-induced proteins such as aromatase, P450 scc , and SF1 was reduced by DBP (Fig. 5E ). Note that DBP did not alter the basal expression of these proteins (Fig. 5 , A-C and E). Taken together, our results indicated that DBP suppresses the biological activity of FSH on GCs.
DBP Induces Similar and Unique Changes in Cultured Follicles
To evaluate the effects of DBP on whole follicles, we performed in vitro follicle culture and DBP treatment. Similarly, we found significantly lower Fshr mRNA level in DBP-treated follicles in comparison with vehicle-treated control follicles (Fig. 6A) . To our surprise, DBP decreased basal mRNA level of Kitlg in follicles (Fig. 6B) , which was not consistent with the effect of DBP on GCs (Fig. 2A) . FSH still stimulated Kitlg expression in the follicles, and DBP inhibited the effect of FSH (Fig. 6B) . Consistent with the GC result, 
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DBP suppressed FSH-induced intracellular signaling such as activation of CREB, AKT and mTOR, as well as HIF1A expression (Fig. 6, C and D) . However, DBP also suppressed basal phosphorylation of the above signaling molecules as well as basal HIF1A expression (Fig. 6, C and D) .
DISCUSSION
The process of ovarian folliculogenesis is characterized by 1) proliferation of the follicular cells that surround the oocyte and 2) growth of the oocyte itself [33] . The mechanisms regulating follicle growth and development are under the control of changing concentrations of ligands (i.e., hormones and growth factors). At the endocrine level, folliculogenesis is regulated by a central nervous system, anterior pituitary, and ovary cascade mechanism. Specialized hypothalamic neurons FIG. 5 . DBP inhibits other FSH-induced effects on GCs. A-C) Nontransduced and lentivirus-transduced GCs were pretreated with 100 lg/ml DBP for 24 h followed by stimulation with 100 ng/ml FSH for an additional 24 h. Expressions of 17-beta-estradiol, progesterone, and aromatase (gene name Cyp19a1) were analyzed by ELISA (A and B) or q-RT-PCR (C). n ¼ 6 per group. D, DBP; N, nontransduced cells; L-HIF, transduction with HIF-expressing lentivirus. D) GCs were pretreated with 100 lg/ml DBP for 24 h followed by stimulation with 100 ng/ml FSH plus 100 ng/ml activin A for an additional 24 h. Proliferation of cells were quantitated by thymidine incorporation analysis. n ¼ 5 per group. D, DBP; A, activin A; N, nontransduced cells; L-HIF, transduction with HIF-expressing lentivirus. E) GCs were pretreated with 100 lg/ml DBP for 24 h followed by stimulation with 100 ng/ml FSH for an additional 24 h. Expressions of FSH-induced genes were analyzed by Western blot. Ctrl, vehicle control; D, DBP; FSH, FSH stimulation; FSHþD, DBP pretreatment followed by FSH stimulation. Left panel: representative image; right panel: statistical analysis for the expression of each protein. n ¼ 4 per group. *P , 0.05; **P , 0.01; ***P , 0.001. 3   FIG. 4 . DBP inhibits PI-3K/HIF1A signaling to suppress KITLG expression. A) GCs were pretreated with 100 lg/ml DBP or 100 lg/ml wortmannin for 24 h followed by stimulation with 100 ng/ml FSH for an additional 24 h. Phosphorylation of AKT, mTOR, and S6K and expression of HIF1A were detected by Western blot. D, DBP; W, wortmannin. B) Statistical analysis for phosphorylation of AKT, mTOR, and S6K, as well as expression of HIF1A. n ¼ 5 per group. C) GCs were pretreated with or without 100 lg/ml DBP for DIBUTYL PHTHALATE IMPAIRS GRANULOSA CELL FUNCTION secrete pulses of gonadotropin-releasing hormone into the portal blood vessels, which acts on the gonadotrophs to cause a pulsatile release of FSH and luteinizing hormone, which in turn act on ovarian follicle cells to control folliculogenesis. GCs are a crucial cell type in the process of folliculogenesis [34] . GCs transmit the endocrine and local ovarian signals responsible for nurturing growth and development of the oocyte [33] .
Because of the ubiquitous presence and excessive worldwide production of DBP, exposure to DBP can occur via ingestion, inhalation, and intravenous or dermal contact [19] . According to exposure estimates, the largest source of DBP exposure to the general population is food and has been estimated to range between 7 and 10 lg/kg/day [35] . Bao et al. reported that in vivo exposure to DBP produced significantly different protein expression profiles in male rat testes (0.1-10 mg/kg/day) and altered reproductive organ morphology (100-500 mg/kg/day) [36] . Further, in utero exposure to DBP at 850 mg/kg/day has been shown to cause anorectal malformations and megacolon in male rats [37] . Oral exposure to DBP (500 and 1000 mg/kg/day) from weaning through puberty, mating, and gestation resulted in increased midpregnancy abortions and decreased ex vivo ovarian hormone production in female rats [38] . Other phthalates, such as di-2-ethylhexyl phthalate, mono(2-ethylhexyl) phthalate, and benzyl butyl phthalate, have been shown to influence the growth and/or development of ovarian follicles or GCs. [39] [40] [41] . DBP changed the expression of genes involved in cell cycle and apoptotic pathways in mouse ovarian antral follicles [19] . A recent study indicates that a 10-day exposure to DBP induces profound influence on reproductive processes in CD-1 mice, including decreased circulating 17b-estradiol, decreased antral follicle numbers, and altered gene expression of apoptosis and steroidogenesis [42] . However, the mechanisms by which DBP mediates these changes have not been fully understood. In particular, DBP-induced alterations of signal transduction in ovarian follicular cells have not been thoroughly investigated. In this study we characterized the impact of DBP on rat GCs. The DBP doses we chose were based on previous studies indicating toxicity of DBP in vitro and in vivo. A study reported that 1000 lg/ml DBP tends to change the expression of apoptotic genes and cell cycle genes in mouse antral follicles, and 100 lg/ml DBP has insignificant effect on most gene expression and follicle growth [19] . In our study, we wanted to avoid the effect of DBP on apoptosis, because dying cells might severely distort the data. Consequently, we chose doses less than 1000 lg/ml. Silva et al. reported a median concentration of total monobutyl phthalate (metabolite of DBP) in serum of 14.4 lg/L of which approximately 25%-30% is free monobutyl phthalate and the remainder is monobutyl phthalate glucuronide [43] . Hence, we selected DBP doses ranging from 5 to 100 lg/ml, which are much higher than the metabolite concentration in normal serum but not enough to induce cell death. The DBP doses we used did not induce significant apoptosis or necrosis, ensuring that the following experimental data might not be interpreted simply as the result of cell death.
FSH is responsible for follicular growth and estrogen production. GCs express FSHR to receive FSH stimulation. FSH has profound influence on GC biology including the proliferation and differentiation of GCs [44] and the regulation of IGF2 expression [45] . Meanwhile, GCs regulate oocyte growth and survival via KITLG [26, 46] . Therefore, we investigated KITLG expression by GCs in the presence of FSH and DBP. Interestingly, both KITLG1 and KITLG2 were reduced by DBP treatment. It is considered that KITLG2 is more effective in promoting oocyte growth than KITLG1 [46] . This means that DBP might indirectly restrain oocyte growth through alleviating the support from GCs, which explains the inhibitory effect of DBP on follicle growth in previous reports. However, whether DBP directly impacts oocyte growth and differentiation is still unknown. It is reported that FSH accelerates and facilitates meiotic progression of oocytes in vitro [47] . Moreover, the presence of functional FSHRs in oocytes has been described [48] . Therefore, DBP might directly influence FSH-mediated oocyte biology.
The effect of DBP on KITLG expression led us to explore the underlying mechanisms of this phenomenon. Unexpectedly, we found that FSHR expression was substantially lower in DBP-treated GCs. Although it seemed that DBP decreased transcription of Fshr through inhibiting Fshr promoter, we still do not know the upstream factor(s) contributing to this effect. Several transcription factors, including upstream stimulatory factor (USF) and SF1, have been shown to regulate Fshr transcription [49, 50] . Hence, further research would clarify the role DBP plays to regulate expression or activity of these factors. FSH accomplishes its actions by inducing a complex pattern of gene expression in target GCs that is regulated by input from many different signaling cascades, including those for the protein kinase A (PKA), extracellular regulated kinases (ERKs), p38 mitogen-activated protein kinases (MAPKs), and PI3K [51] . These signal pathways are deeply involved in cell survival, proliferation, and differentiation. DBP-induced reduction of FSHR would impair these signal pathways, leading to broad alterations of GC growth and survival. Further investigation will be needed to dissect the impact of DBP on these signal pathways.
To our knowledge, how FSH stimulates KITLG expression has not been completely understood. It has been shown that FSH enhances expression of HIF1A in GCs and other cell types [28, 29, 51] . HIF1A is a heterodimeric DNA-binding complex composed of two basic helix-loop-helix proteins of the PAS family. HIF1A modulates multiple biological processes, including metabolic adaption, angiogenesis, carcinogenesis, apoptosis, cell proliferation and migration [52] [53] [54] . Moreover, HIF1A has been shown to directly regulate KITLG expression [30, 31] . Therefore, we investigated HIF1A's involvement in the regulation of KITLG expression by FSH. We found that the HIF1A level was reduced by treatment with the PI3K inhibitor wortmannin. Moreover, overexpression of HIF1A by lentiviral transduction restored KITLG expression after DBP treatment. Thus, it is possible that FSH stimulates PI3K-AKT-mTOR signaling to up-regulate the HIF1A level, and HIF1A subsequently triggers KITLG transcription. Other transcription factors, such as p38MAPK, ERK1/2, and NFKB, are also involved in transcription of KITLG [55] . FSH can activate these transcription factors [56] [57] [58] . Therefore, whether FSH activates these factors in GCs, and whether DBP also interrupts FSH-induced activation of these factors, needs further investigation.
The effect of DBP on FSH-induced production of estradiol and progesterone was also tested in our study. We found that DBP inhibited FSH-induced production of these sex hormones, but did not change the basal levels. However, a previous study indicated that DBP decreases basal estradiol production but does not influence progesterone production by mouse ovarian antral follicles [19] . In that study, the effect of DBP on estradiol production was significant only after 96-h treatment, while in our experiments the treatment lasted only for 48 h. Another explanation for this disparity is that the follicles (including GCs) we used were at a different stage (preantral) from theirs (antral). It has been demonstrated that during ovarian follicle development, both oocytes and GCs undergo profound changes in gene expression profile, even when these cells are in the same developmental stage but in distinct phases [59] [60] [61] [62] . It is likely that GCs at different developmental stages respond differentially to DBP treatment, because of differential expression of signaling proteins and metabolic molecules. In addition, we used rat cells whereas they used mouse cells. Although most genes are highly homologous between mice and rats, mouse cells do not necessarily respond to stimuli/insults the same as rat cells do, even when they are the same cell type. Differential properties and responsiveness of mouse and rat cells of the same type have been implicated by previous reports [63] [64] [65] . Therefore, species difference should always be taken into account.
Although exogenous HIF-1A restored KITLG expression in DBP-treated cells, it failed to restore the production of estradiol and progesterone. This phenomenon suggests that HIF-1A might not play a role in the regulation of estradiol and progesterone levels. Another explanation is that restoration of HIF-1A protein level might not be sufficient to functionally restore HIF-1A activity on DBP-inhibited steroid production. DBP might directly inhibit the expression or activity of enzymes converting cholesterol into progesterone and estradiol, such as p450 scc , aromatase, etc. Indeed, we found that FSHinduced aromatase expression is decreased by DBP. Therefore, DBP might block the biosynthesis pathways of estradiol and progesterone, and HIF-1A itself could not restore them. This hypothesis needs to be verified by further investigation.
The disparity between the effects of DBP on GCs and follicles suggests that DBP-induced alterations might be more complicated in the whole follicle, because the oocyte and theca cells might also be influenced by DBP, and the interactions between different cell types might cause changes in the responsiveness of GCs to DBP. Another possibility is that DBP might block these cells' signaling through unidentified mechanisms in addition to down-regulation of FSHR. Further investigation will be performed to test these possibilities.
Collectively, our research disclosed a novel mechanism by which DBP impairs GC function. Animal study is needed to test whether this mechanism is present in vivo, and how it can influence the ovarian follicle development and maturation. Our findings may provide clues for preventing or treating DBPinduced damage to GCs.
